Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Objective to assess the effectiveness of prophylactic bilateral uterine artery ligation (BUAL) in reducing the incidence of postpartum hemorrhage during cesarean delivery among women with twin pregnancy
A randomized clinical trial at Aswan University Maternity Hospital, Egypt. Women with twin pregnancy undergoing scheduled or emergency cesarean were randomized into two groups. In the BUAL group, women underwent BUAL before placental delivery; in the control group, women had cesarean delivery without BUAL. The primary outcome was the estimated blood loss during a cesarean
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| study group | Experimental | patients with twin pregnancy undergoing cesarean section underwent bilateral uterine artery ligation and received oxytocin. |
|
| control group | Active Comparator | patients with twin pregnancy undergoing cesarean section received oxytocin only. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| bilateral uterine artery ligation | Procedure | The peritoneum over the vesico-uterine pouch already being incised horizontally, the peritoneum over the uterine isthmus and cervix was dissected downwards, and this dissection was then extended laterally |
| Measure | Description | Time Frame |
|---|---|---|
| mean Blood loss after placental separation | by using weight of soaked towels (weight of soaked towel - weight of dry towel) and amount of blood in suction set | 30 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants with postpartum hemorrhage | number pf participants with blood loss > 1000ml | 12 hours |
| The number of participant needed for blood transfusion | Calculation of the number of participant needed for blood transfusion |
Not provided
Inclusion Criteria:
Exclusion Criteria:
pregnant women with twin pregnancy undergoing cesarean section
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| hany f Sallam, md | Contact | +20102435461 | 002 | hany.farouk@aswu.edu.eg |
| nahla w Shady, md | Contact | +201022336052 | 002 | hanygyne@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| nahla w Shady, md | Aswan universirty | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aswan University Hospital | Recruiting | Aswān | 81528 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010121 | Oxytocin |
| ID | Term |
|---|---|
| D010909 | Pituitary Hormones, Posterior |
| D010907 | Pituitary Hormones |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
Not provided
Not provided
randomized controlled study
Not provided
Not provided
open label randomized controlled study
Not provided
|
| Oxytocin | Drug | 20 units by slow intravenous drip injection |
|
| 24 hours |
| D006730 |
| Hormones, Hormone Substitutes, and Hormone Antagonists |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |